Genentech, Inc. has entered into an agreement with Lonza Group, Ltd. for the sale of Genentech’s manufacturing facility in Porrino, Spain for $150 million. The company has also entered into a supply agreement for the manufacture of certain products at Lonza’s facility that is currently under construction in Singapore. Genentech will also have the right to exercise an exclusive option to purchase the Singapore facility. Under the terms of the agreement, Lonza will acquire Genente...